Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Lawrence

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Circulation|June 27, 2001
Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxideM M Mocanu, H L Maddock, G F Baxter, et al.
Journal of Pharmacological and Toxicological Methods|November 6, 2007
Optimisation and validation of a medium-throughput electrophysiology-based hNav1.5 assay using IonWorksA R Harmer, N Abi-Gerges, A Easter, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Circulation|June 27, 2001
Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxideM M Mocanu, H L Maddock, G F Baxter, et al.
Journal of Pharmacological and Toxicological Methods|November 6, 2007
Optimisation and validation of a medium-throughput electrophysiology-based hNav1.5 assay using IonWorksA R Harmer, N Abi-Gerges, A Easter, et al.
Pageof 2